Home
Live Updates
FDA Grants Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis : vimarsana.com
FDA Grants Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis
The primary outcome was a 90-day incidence of mortality or liver transplant for individuals who received larsucosterol, compared to the placebo group.
Related Keywords
Danil Nikonov ,
Jamese Brown ,
Corporation Receives ,
National Library Of Medicine ,
National Library ,
Therapy Designation ,
More Than Half ,
Not Aware ,
Link Between Alcohol ,
vimarsana.com © 2020. All Rights Reserved.